Categories
Pharmaceutical

Sales of Benzodiazepine Drugs Market Set to Record US$ 2.6 Bn by 2026

The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs is reflecting on increasing opportunities for players in the U.S. market. As per a report by the Anxiety and Depression Association of America (ADAA), each year, over 40 Mn adults in the U.S. suffer from anxiety disorders.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4432

Presence of a large number of hospital and retail pharmacies further makes it easy for individuals to purchase benzodiazepine drugs. A significant influence of high concentration of leading players is also auguring well for the U.S. benzodiazepine drugs market, which has been discussed in detail, in a recent Fact.MR study.

analysis of benzodiazepine drugs market by application

Key Highlights of Benzodiazepine Drugs Market Study

  • Easy accessibility is a key feature driving substantial sales of benzodiazepine drugs through retail pharmacies. By 2026, these pharmacies are projected to record value tantamount to US$ 1.4 Bn. Additionally, sales prospects for benzodiazepine drugs are likely to grow during the forecast period, as consumers are evincing high interest in online pharmacies.
  • Popularity of short-acting benzodiazepine drugs is expected to increase during the forecast period, as these induce less hangover effect and take relatively short time of action. On the back of this, around 77% of the total share would be attributable to the sales of short-acting benzodiazepine drugs.
  • Being a highly prevalent disorder among individuals leading a demanding lifestyle, anxiety is projected to account for a sizeable share tantamount to around 53% in the benzodiazepine drugs market during the forecast period.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4432

  • Reduction in the number of prescriptions for benzodiazepine drugs, especially in countries such as the U.S., the U.K., and Canada, would impede market growth during the forecast period.

Benzodiazepine Drugs Market – Assessment of Key Segments

This detailed study also offers information about the incremental opportunity present in the benzodiazepine drugs market during the forecast period. Key segments considered while studying the benzodiazepine drugs market include:

Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Time of Action
  • Ultra-short Acting
  • Short Acting
  • Long Acting
Application
  • Anxiety
  • Seizures
  • Insomnia
  • Alcohol Withdrawal
  • Others

High Popularity of Generic Drugs Puts Pressure on Branded Products of Leading Players

The benzodiazepine drugs market features fragmentation, as leading players operate under the constant pressure of patent expiration of branded products. High investments made towards the development of innovative and new products by leading players intensifies pressure to achieve the desired RoI. For instance, in 2017, F.Hoffmann-La Roche AG invested around one-fifth of the total revenue to strengthen the pipeline of innovative products. Stringent regulations on innovative drugs further make it difficult for leading players to gain desired marketability.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4432

On the other side, the focus of prominent and leading players is on achieving better penetration into the benzodiazepine drugs market through the development of generic drugs. Growing sales of generic benzodiazepine drugs is putting pressure on leading players to squeeze their profit margins and adopt a cost-competitive strategy to have better sales prospects.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/31/2009232/0/en/Fact-MR-Forecasts-Sales-of-Audiological-Devices-to-Exceed-US-13-Bn-by-2026-Receiver-in-the-ear-Will-Remain-Bestselling-Reveals-a-New-Report.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Lung Management Products Market Forecast, Trend Analysis & Competition Tracking-Global Market Insights 2018 to 2028- https://www.factmr.com/report/2030/lung-management-products-market

Primary Hyperoxaluria Treatment Market Forecast, Trend Analysis, & Competition Tracking – Global Market Insights 2020 to 2030- https://www.factmr.com/report/5257/primary-hyperoxaluria-treatment-market

Surgical AR Systems Market Forecast, Trend Analysis, & Competition Tracking – Global Review 2020 to 2030- https://www.factmr.com/report/5258/surgical-ar-systems-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com